Results 1 to 10 of about 886,573 (305)

Frequency of thrombocytopenia in severe COVID-19

open access: yesPakistan Journal of Pharmaceutical Sciences, 2022
To aim of the study was to determine the frequency of thrombocytopenia and its effect on clinical outcomes in South Asian patients admitted with severe COVID-19.
Mehak Hanif   +4 more
doaj   +1 more source

Ventilator-associated events: From surveillance to optimizing management

open access: yesJournal of Intensive Medicine, 2023
Mechanical ventilation (MV) is a life-support therapy that may predispose to morbid and lethal complications, with ventilator-associated pneumonia (VAP) being the most prevalent.
Sergio Ramirez-Estrada   +3 more
doaj   +1 more source

New respiratory syncytial virus immunization products in low- and middle-income countries: potential for cost-effective impact on a high burden of disease in young infants

open access: yesBMC Medicine, 2023
As new, efficacious respiratory syncytial virus (RSV) immunization products reach the market, affordable pricing as well as improved estimation of disease burden and the full potential and cost effectiveness of RSV prevention in the hardest hit ...
Padmini Srikantiah, Keith P. Klugman
doaj   +1 more source

Innate immune responses in pneumonia

open access: yesPneumonia, 2023
The lungs are an immunologically unique environment; they are exposed to innumerable pathogens and particulate matter daily. Appropriate clearance of pathogens and response to pollutants is required to prevent overwhelming infection, while preventing ...
Filiz T. Korkmaz, Katrina E. Traber
doaj   +1 more source

Effects of pneumococcal conjugate vaccines on reducing the risk of respiratory disease associated with coronavirus infection

open access: yesPneumonia, 2023
Pneumococcal conjugate vaccines (PCVs) provide protection against vaccine-type pneumococcal disease in both children and adults. Growing evidence suggests that PCVs also reduce pneumonia and lower respiratory tract infections (LRTIs) more broadly ...
Eileen M. Dunne   +4 more
doaj   +1 more source

Risk of subsequent lower respiratory tract infection (LRTI) after hospitalization for COVID-19 LRTI and non-COVID-19 LRTI: a retrospective cohort study

open access: yesPneumonia, 2023
Background Respiratory pathogens, including SARS-CoV-2, can cause pulmonary structural damage and physiologic impairment, which may increase the risk of subsequent lower respiratory tract infections (LRTI).
Katia J. Bruxvoort   +8 more
doaj   +1 more source

A brief history of and future prospects for pneumococcal vaccination in Malaysia

open access: yesPneumonia, 2023
Pneumococcal pneumonia remains a significant global public health issue. Malaysia has recently added the 10 valent pneumococcal conjugate vaccine to its national immunisation programme.
Alex J. J. Lister   +4 more
doaj   +1 more source

The expansive effects of polyamines on the metabolism and virulence of Streptococcus pneumoniae

open access: yesPneumonia, 2021
Polyamines are common intracellular metabolites of nearly all cells, and their conservation across a vast diversity of cells suggests critical roles for these compounds in cellular physiology.
Bindu Nanduri, Edwin Swiatlo
doaj   +1 more source

Case report on a defective antibody response against pneumococcal serotype 9V in a patient with a single episode of pneumonia

open access: yesPneumonia, 2017
Background Patients with recurrent respiratory tract infections and an impaired response to pneumococcal polysaccharide vaccination are diagnosed with a specific antibody deficiency.
Diana van Kessel   +6 more
doaj   +1 more source

The impact of certain underlying comorbidities on the risk of developing hospitalised pneumonia in England

open access: yesPneumonia, 2019
Background UK specific data on the risk of developing hospitalised CAP for patients with underlying comorbidities is lacking. This study compared the likelihood of hospitalised all-cause community acquired pneumonia (CAP) in patients with certain high ...
J. Campling   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy